Calibrate, a telehealth company that prescribes obesity drugs and provides weight loss coaching, cut 18% of its workforce amid growing competition from digital medicine companies.
The company will focus more on partnering with employers to provide services to their workers, the company said in a statement. “Calibrate is accelerating our transformation into an Enterprise-first business, shifting internal resources and restructuring our team,” the company said. Still, “we will continue to grow our direct-to-consumer business responsibly.”
The moves come as more digital health providers seek to offer access to new, highly-effective obesity medications such as Novo Nordisk’s Wegovy. Ro, for example, has prominently advertised its weight loss services, plastering posters featuring Wegovy across subway stations. Last month, WW International, known as WeightWatchers, said it would buy telehealth company Sequence, which prescribes these drugs.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
